|
Volumn 53, Issue 3, 2004, Pages 1111-1126
|
Race as a proxy for drug response: the dangers and challenges of ethnic drugs.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDRALAZINE;
ISOSORBIDE DINITRATE;
ISOSORBIDE HYDRALAZINE COMBINATION;
ISOSORBIDE-HYDRALAZINE COMBINATION;
AFRICAN AMERICAN;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
COMMERCIAL PHENOMENA;
CONFLICT OF INTEREST;
CONGESTIVE HEART FAILURE;
DRUG COMBINATION;
DRUG INDUSTRY;
ECONOMICS;
ETHNIC GROUP;
GENETICS;
GENETICS AND REPRODUCTION;
HEALTH CARE AND PUBLIC HEALTH;
HUMAN;
PHARMACOGENETICS;
RACE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
HEALTH CARE AND PUBLIC HEALTH;
AFRICAN AMERICANS;
CLINICAL TRIALS;
COMMERCE;
CONFLICT OF INTEREST;
CONTINENTAL POPULATION GROUPS;
DRUG COMBINATIONS;
DRUG INDUSTRY;
ETHNIC GROUPS;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
PHARMACOGENETICS;
|
EID: 32944471021
PISSN: 00117188
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (12)
|
References (0)
|